Clinical trial
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
NCT02295059
Study timeline
Study start (actual)2017-08-09Date precision: day
Registry last updated2026-04-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
omega 3 fatty acidsDIETARY_SUPPLEMENT
Sponsors & collaborators
City of Hope Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02295059 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.